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Accumulating evidence indicates that the gut microbiota affects colorectal cancer develop-
ment, but previous studies have varied in population, technical methods, and associations
with cancer. Understanding these variations is needed for comparisons and for potential
pooling across studies. Therefore, we performed whole-genome shotgun sequencing on
fecal samples from 52 pre-treatment colorectal cancer cases and 52 matched controls from
Washington, DC. We compared findings from a previously published 16S rRNA study to the
metagenomics-derived taxonomy within the same population. In addition, metagenome-
predicted genes, modules, and pathways in the Washington, DC cases and controls were
compared to cases and controls recruited in France whose specimens were processed
using the same platform. Associations between the presence of fecal Fusobacteria, Fuso-
bacterium, and Porphyromonas with colorectal cancer detected by 16S rRNA were repro-
duced by metagenomics, whereas higher relative abundance of Clostridia in cancer cases
based on 16S rRNA was merely borderline based on metagenomics. This demonstrated
that within the same sample set, most, but not all taxonomic associations were seen with
both methods. Considering significant cancer associations with the relative abundance of
genes, modules, and pathways in a recently published French metagenomics dataset, sta-
tistically significant associations in the Washington, DC population were detected for four
out of 10 genes, three out of nine modules, and seven out of 17 pathways. In total, colorectal
cancer status in the Washington, DC study was associated with 39% of the metagenome-
predicted genes, modules, and pathways identified in the French study. More within and
between population comparisons are needed to identify sources of variation and disease
associations that can be reproduced despite these variations. Future studies should have
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larger sample sizes or pool data across studies to have sufficient power to detect associa-
tions that are reproducible and significant after correction for multiple testing.
Introduction
The human microbiome is the subject of a growing area of research since it is likely related to
human health and disease. There is accumulating evidence that the microbiome plays a role in
colorectal cancer (CRC) development or progression, potentially through inflammatory path-
ways or carcinogenic microbial metabolites [1], and microbial associations with CRC have
been suggested in a number of studies [2–9]. For example, with next generation sequencing of
the universal bacterial 16S rRNA gene in DNA extracted from feces, our group has shown that,
compared to matched controls, CRC cases have lower community diversity, modestly lower
relative abundance of Clostridia, and higher presence of Fusobacterium and Porphyromonas
[2]. Of the previous microbiome and CRC studies, some used 16S rRNA gene sequencing [2, 4,
5, 7, 9], while others used whole-genome shotgun sequencing/shotgun metagenomics (WGSS;
[3, 6, 8]). WGSS yields not only profiles of bacterial composition and diversity, but also esti-
mates the functional potential of the microbiome [10].
We performed shotgun metagenomic sequencing of fecal samples from a CRC case-control
study conducted in the 1980s in Washington, DC that were previously analyzed by 16S rRNA
gene sequencing [2]. By subjecting the same samples to a different sequencing method, we
were able to compare the previously observed 16S rRNA associations with data from shotgun
metagenomic sequencing. In addition, by using this technology, we were able to investigate
potential microbial gene-level associations with CRC which was not possible in the 16S rRNA
gene sequencing data, and we compared gene-level associations with those detected in a previ-
ous French case-control study that applied the same metagenomics DNA extraction and
sequencing platform and bioinformatics pipeline [8].
Materials and Methods
Primary study population
The fecal samples were collected in a CRC case-control study that has been previously
described in detail [11] and the description of the analysis of the respective 16S rRNA gene
sequencing study was previously published [2]. Briefly, CRC cases and frequency matched con-
trols who were waiting surgery for non-oncological and non-gastrointestinal conditions were
recruited from 1985 to 1987 in Washington DC, United States. Prior to surgery or other treat-
ment, participants collected all stools over a two day period and stored them on dry ice. At the
laboratory, the samples were freeze-dried, pooled, and stored continuously thereafter at -40°C.
For the current shotgun metagenomic study, we selected samples from 52 cases and 52 controls
(population WGSS DC). The cases and controls were matched by sex and body mass index
(BMI;< 20 kg/m2 or 20 kg/m2). Associations in the WGSS DC analysis were compared to
those in the previous 16S rRNA gene sequencing study (population 16S DC), which included
47 CRC cases and 94 control subjects from the same parent study. All 47 CRC cases from 16S
DC were included in the WGSS DC and the 52 controls in WGSS DC were included in the 94
controls from 16S DC. Participants provided written informed consent and this study was
approved by the Office of Human Subjects Research at the National Institutes of Health.
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Independent validation population
We included data from a previously published study (population F) as an independent valida-
tion set [8]. In brief, CRC cases and randomly chosen controls were recruited from 2004 to
2006 in Paris, France. Prior to colonoscopy, a fresh stool sample was collected and frozen at
-20°C within four hours of collection. Population F included 53 CRC cases, 15 large adenoma
cases, 27 small adenoma cases, and 61 normal controls. Since the controls fromWashington
DC may have also included undiagnosed small adenomas, the comparison case-control set
from population F included 53 CRC cases and 88 controls (i.e., 27 small adenomas and 61 nor-
mal controls) and excluded the data from the 15 large adenomas.
We also included publically available shotgun metagenomic data from 292 MetaHIT partic-
ipants [12, 13] and 94 Human Microbiome Project (HMP) Phase I participants [14] for com-
parison of overall diversity, richness, and evenness with our samples.
DNA extraction and whole-genome shotgun sequencing
The freeze-dried fecal samples fromWGSS DC were defrosted, resuspended in phosphate-
buffered saline, and an aliquot was shipped to the Genomics Core Facility, European Molecular
Biology Laboratory in Heidelberg, Germany on dry ice. The methods for DNA extraction,
library preparation, and whole-genome shotgun sequencing have been described in detail [8]
and were the same for population WGSS DC and population F. In brief, DNA was extracted
from the fecal samples using the GNOME DNA Isolation Kit (MP Biomedicals) with minor
modifications. Whole-genome shotgun sequencing of the extracted DNA was conducted using
the Illumina HiSeq 2000/2500 (Illumina, San Diego, USA). The samples were sequenced with a
100-bp read length for paired-end sequences at the Genomics Core Facility, European Molecu-
lar Biology Laboratory, Heidelberg, Germany with a targeted sequencing depth of 5 Gbp.
Bioinformatics
The general strategy for the bioinformatic processing of the whole-genome sequencing data
has been previously described in detail [8] and was the same for both WGSS DC and popula-
tion F. Taxonomic abundance profiles summarized at NCBI taxonomic ranks ranging from
species to phylum and metagenomic operational taxonomic units (mOTU) [15, 16] were cre-
ated using MOCAT [17]. MOCAT was also used to functionally annotate genes extracted from
metagenomic assemblies to the KEGG database (version 62) [18]. Ecological indices (Shannon
diversity, species richness, and community evenness) were calculated based on mOTU relative
abundances and downsampled to 2000 inserts using the vegan R software package [19]. One
participant from population WGSS DC and four participants from population F were excluded
due to lower read coverage.
Statistical analysis
We compared Shannon diversity, richness, and evenness for population WGSS DC, population
F, MetaHIT, and HMP Phase I samples and tested case-control differences in population
WGSS DC and population F using the Kruskal Wallis test. Then, for both the primary study
population (population WGSS DC: 52 cases vs 52 controls) and the independent validation
population (population F: 53 cases vs 88 controls), we tested for the associations between case/
control status and both the relative abundance and presence/absence of the different taxo-
nomic levels and gene categories (i.e., genes, modules, and pathways). A logistic regression
model with adjustment for age, sex, and body mass index (BMI) was used and the p values
were calculated based on the Wald test (S1 Table). Three CRC cases from population WGSS
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DC were missing BMI data so we included these values using sex-specific means of the CRC
cases. For comparability with the 16S DC study, we also calculated an unadjusted logistic
regression model for a two-sided Wald chi-squared test and a two-sided non-parametric Wil-
coxon test for presence/absence and relative abundance of specific taxa, respectively. We gener-
ated QQ plots of the—log(observed p value) versus the—log(p values under a normal
distribution) within WGSS DC and population F for all taxonomic levels and gene categories
to ascertain potentially statistically significant associations after correction for multiple com-
parisons. For the gene category data in population F, we used Bonferroni correction of the p
value to determine statistical significance (i.e., p< 0.05/number of tests) and considered a p
value< 0.05 to be statistically significant for reproducibility analyses in WGSS DC. All statisti-
cal analyses were conducted using R (version 3.0.0).
Results
Characteristics of the 52 CRC cases and 52 controls from population WGSS DC are presented
in Table 1. They were well matched by sex and BMI. However, CRC cases had a higher propor-
tion of non-Hispanic blacks (23.1% in cases and 5.8% in controls), lower education level
(15.4% of cases and 3.8% of controls had less than a high school education), and more current
smokers (13.5% of cases and 3.8% of controls). Within the CRC cases, 28.8% of cases had can-
cer in the right colon and 34.6% had cancer in the left colon. The majority of CRCs were inva-
sive with no known metastases (40.4%), but 34.6% were metastatic.
Colorectal cancer associations in the WGSS DC versus 16S DC
In the previous 16S rRNA gene sequencing analysis in this population (16S DC), the presence
of 4 taxa and the relative abundance of 3 taxa were significantly associated with CRC case status
with false discovery rate-adjusted p values less than 0.05. As seen in Table 2, we reproduced a
significant association between the presence of the Fusobacteria phyla and CRC case status
(p = 0.003), specifically that 76.9% of cases and 48.1% of controls had detectable Fusobacteria.
This reproduces the association of Fusobacteria with case status in the 16S DC analysis;
although detection was lower (36.2% of cases and 16.0% of controls, Table 2). Compared to the
16S DC, the WGSS also had higher prevalent detection rate for other taxa, and it reproduced a
significant association between the presence of Fusobacterium (p = 0.006) and Porphyromonas
(p = 0.032) with CRC case status. The association between Atopobium and CRC from the 16S
DC was not reproduced in the WGSS (Table 2). As seen in Table 3, we did not reproduce asso-
ciations between the relative abundance of specific taxa and CRC case status, although the asso-
ciation between the relative abundance of Clostridia tended to be lower in cases (p = 0.092).
Notably, relative abundance of Clostridia estimated in the WGSS was two-fold lower for both
cases and controls compared to that in the 16S DC study. In population WGSS DC, the class
with a highest relative abundance was Bacteroidia, which had a relative abundance of 53.2% in
cases and 50.9% in controls (S1 Table).
Colorectal cancer associations in the WGSS DC versus Population F
In population WGSS DC, there were no significant differences between CRC cases and controls
for Shannon diversity, richness, or evenness based on mOTUs, although in general the controls
had slightly higher alpha diversity compared to cases (Fig 1). Shannon diversity, richness, and
evenness were similar for population WGSS DC, population F, and the MetaHIT samples,
whereas the HMP samples tended to have slightly lower Shannon diversity, richness, and
evenness.
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CRC case status in population F [8] was strongly associated with the relative abundance of
many metagenome-derived KEGG genes, modules, and pathways (as seen by the strong devia-
tion from the 45° degree line in Fig 2), but this was not seen in the WGSS DC population. For
the presence of KEGG genes, modules, and pathways, there was little evidence for any associa-
tions with CRC case status in either study population (Fig 2). Since associations were detected
for the relative abundance of the gene-level data only in population F, we attempted to repro-
duce statistically significant associations after Bonferroni correction in population F with the
WGSS DC data without correction for multiple comparisons.
Table 1. Descriptive characteristics of the colorectal cancer cases and controls (populationWGSS
DC), Washington DC, USA, 1985–1987.
Cases Controls
N = 52 N = 52
N/Mean %/SD N/Mean %/SD
Sex
Male 37 71.2% 37 71.2%
Female 15 28.8% 15 28.8%
Age 61.8 13.6 61.2 11.0
Race
Non-Hispanic white 39 75.0% 47 90.4%
Non-Hispanic black 12 23.1% 3 5.8%
Other 1 1.9% 2 3.8%
Education
Less than high school 8 15.4% 2 3.8%
High school graduate 11 21.2% 10 19.2%
1–3 years of college/graduate 10 19.2% 9 17.3%
4–5 years of college/graduate 12 23.1% 15 28.8%
6+ years of college/graduate 8 15.4% 16 30.8%
Missing data 3 5.8% 0 0.0%
Smoking history
Never 24 46.2% 22 42.3%
Former 18 34.6% 28 53.8%
Current 7 13.5% 2 3.8%
Missing data 3 5.8% 0 0.0%
Body mass index 24.9 4.2 25.3 4.3
Alcohol (drinks/wk) 7.4 11.9 6.1 10.4
Cancer site
Right colon 15 28.8% NA
Left colon 18 34.6% NA
Rectal 14 26.9% NA
Missing data 5 9.6% NA
Cancer stage NA
Pre-invasive 12 23.1% NA
Invasive, no known metastases 21 40.4% NA
Known metastases 18 34.6% NA
Missing data 1 1.9% NA
NA: Not applicable
doi:10.1371/journal.pone.0155362.t001
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In contrast to the global assessment (Fig 2), when we considered the significant associations
between the relative abundance of KEGG genes (p< 0.05/8028), modules (p< 0.05/485), and
pathways (p< 0.05/318) within population F, the cancer associations were reproduced
(p< 0.05) in the WGSS DC for four of 10 genes: aminomethyltransferase (K00605), tryptopha-
nase (K01667), peptide methionine sulfoxide reductase msrA/msrB (K12267), and putative
membrane protein (K01421) (Table 4). Likewise, the WGSS DC reproduced cancer associa-
tions for three of nine modules: leucine degradation, leucine => acetoacetate + acetyl-CoA
(M00036), citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate (M00011),
and methionine biosynthesis, apartate => homoserine =>methionine (M00017) (Table 5).
Out of the 17 statistically significant pathway associations in population F, the WGSS DC
reproduced associations with seven pathways: citrate cycle (ko00020), lipoic acid metabolism
(ko00785), valine, leucine, and isoleucine degradation (ko00280), amyotrophic lateral sclerosis
(ko05014), lysine biosynthesis (ko00300), geraniol degradation (ko00281), and nitrogen
metabolism (ko00910) (Table 6). No additional significant associations with CRC were found
in the WGSS DC.
Discussion
This study had two primary aims: 1) to compare the previously observed 16S rRNA gene asso-
ciations with data from whole-genome shotgun metagenomic sequencing; and 2) to investigate
potential microbial gene-level associations with CRC in different populations. For the first aim,
the metagenomics approach reproduced some of the previously observed associations in the
16S rRNA gene analysis, most notably higher likelihood of detecting taxa in the Fusobacteria
Table 2. Comparison of significant taxa detected in 16S rRNA gene sequencing data with whole-genome shotgun sequencing data (presence/
absence of taxa).
Population 16S DC Population WGSS DC
Case Control Case Control
Taxa (phylum; class; order; family; genus) % % P1 % % P1
Fusobacteria (phylum) 36.2 16.0 0.007 76.9 48.1 0.003
Fusobacteria;Fusobacteria;Fusobacteriales;Fusobacteriaceae;Fusobacterium 31.9 11.7 0.004 75.0 48.1 0.006
Actinobacteria;Actinobacteria;Coriobacteriales;Coriobacteriaceae;Atopobium 19.2 2.1 <0.001 53.8 44.2 0.328
Bacteroidetes;Bacteroidia;Bacteriodales;Porphyromonadaceae;Porphyromonas 27.7 7.5 0.001 61.5 40.4 0.032
1 P value based on two-sided chi-squared test
doi:10.1371/journal.pone.0155362.t002
Table 3. Comparison of significant relative abundance of taxa detected in 16S rRNA gene sequencing data with whole-genome shotgun sequenc-
ing data.
Population 16S DC Population WGSS DC
Case Control Case Control
Taxa (phylum; class; order; family; genus) % % P1 % % P1
Firmicutes;Clostridia (class) 68.6 77.8 0.005 33.9 39.0 0.092
Firmicutes;Clostridia;Clostridiales;Lachnospiraceae;Coprococcus 1.7 3.7 0.002 1.2 1.4 0.977
Firmicutes;Clostridia;Clostridiales;Lachnospiraceae;Other 16.1 21.2 0.005 NA2 NA2 NA2
1 P value based on two-sided non-parametric Wilcoxon test
2 It was not possible to estimate the “other” genus using whole-genome shotgun metagenomics
doi:10.1371/journal.pone.0155362.t003
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phylum and Fusobacterium genus among CRC cases. One large difference between the two
studies was the sensitivity for detecting taxa. For example, the Fusobacteria phyla was detected
in 36.2% of the cases and 16.0% of the controls in the 16S rRNA gene study, but using whole-
genome shotgun metagenomics, Fusobacteria was detected in 76.9% of the cases and 48.1% of
Fig 1. Comparison of Shannon diversity index, species richness, and community evenness for fecal samples from the
HumanMicrobiome Project (HMP) Phase I (N = 94), MetaHIT (N = 292), and colorectal cancer cases and controls from
populationWGSS DC and population F. Statistical differences between colorectal cancer cases and controls were tested using
the Kruskal-Wallis test.
doi:10.1371/journal.pone.0155362.g001
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Fig 2. QQ plot of p values for the association between the relative abundance (top) and presence/absence (bottom) of KEGG genes,
modules, and pathways with colorectal cancer case status from fecal samples from populationWGSS DC and population F.
doi:10.1371/journal.pone.0155362.g002
Table 4. Statistically significant associations after Bonferroni correction (p < 0.05/8028) between the relative abundance of a gene and colorectal
cancer case status from population F and observed associations from populationWGSS DC.
Population F Population WGSS DC
Case Control P1 Case Control P1
K00605 0.034% 0.021% 4.15E-07 0.037% 0.032% 3.00E-02
K07173 0.045% 0.056% 5.64E-07 0.045% 0.047% 4.18E-01
K01667 0.020% 0.010% 1.29E-06 0.021% 0.016% 1.20E-02
K12267 0.030% 0.019% 2.08E-06 0.031% 0.026% 2.74E-02
K00177 0.038% 0.025% 3.36E-06 0.040% 0.037% 1.10E-01
K01421 0.068% 0.101% 3.36E-06 0.065% 0.075% 3.91E-02
K01586 0.081% 0.092% 4.67E-06 0.087% 0.091% 8.39E-02
K00176 0.031% 0.020% 4.75E-06 0.029% 0.027% 3.22E-01
K01963 0.036% 0.048% 5.04E-06 0.036% 0.039% 9.38E-02
K00394 0.011% 0.019% 5.51E-06 0.010% 0.011% 5.98E-01
Note: Genes in bold were reproduced (p < 0.05) in population WGSS DC
1 P value based on two-sided Wald chi-squared test after adjustment for age, sex, and body mass index
doi:10.1371/journal.pone.0155362.t004
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the controls. It is unclear what may cause the differences between the 16S rRNA andWGSS
results, but it may be due to the 16S rRNA gene variable region sequenced, the depth of
sequencing, the bioinformatic assignment of taxonomy, or technical differences. These varia-
tions in detecting the presence and relative abundance of taxa demonstrate an important
Table 5. Statistically significant associations after Bonferroni correction (p < 0.05/485) between the relative abundance of a module and colorectal
cancer case status from population F and observed associations from populationWGSS DC.
Population F Population WGSS DC
Case Control P1 Case Control P1
M00311 0.342% 0.226% 3.32E-06 0.376% 0.349% 1.45E-01
M00036 0.266% 0.221% 6.42E-06 0.270% 0.253% 2.14E-02
M00011 1.056% 0.834% 1.40E-05 1.157% 1.087% 4.51E-02
M00045 0.163% 0.096% 1.48E-05 0.198% 0.174% 5.78E-02
M00017 0.781% 0.841% 2.03E-05 0.784% 0.807% 2.32E-02
M00185 0.095% 0.147% 2.16E-05 0.081% 0.081% 9.67E-01
M00144 0.646% 0.483% 3.57E-05 0.727% 0.672% 8.97E-02
M00373 0.276% 0.222% 4.42E-05 0.298% 0.280% 6.24E-02
M00173 1.721% 1.519% 5.44E-05 1.815% 1.783% 3.72E-01
Note: Modules in bold were reproduced (p < 0.05) in population WGSS DC
1 P value based on two-sided Wald chi-squared test after adjustment for age, sex, and body mass index
doi:10.1371/journal.pone.0155362.t005
Table 6. Statistically significant associations after Bonferroni correction (p < 0.05/318) between the relative abundance of a pathway and colorectal
cancer case status from population F and observed associations from populationWGSS DC.
Population F Population WGSS DC
Case Control P1 Case Control P1
ko00020 1.083% 0.944% 2.48E-06 1.103% 1.064% 3.54E-02
ko00785 0.071% 0.045% 3.31E-06 0.075% 0.065% 2.12E-02
ko00280 0.385% 0.323% 3.65E-06 0.382% 0.358% 2.91E-03
ko04964 0.052% 0.035% 4.56E-06 0.052% 0.048% 1.70E-01
ko00400 1.245% 1.335% 4.22E-05 1.239% 1.258% 2.08E-01
ko00430 0.245% 0.226% 4.68E-05 0.248% 0.244% 3.23E-01
ko00195 0.615% 0.717% 5.53E-05 0.640% 0.669% 1.44E-01
ko00627 0.162% 0.134% 6.29E-05 0.159% 0.150% 9.51E-02
ko05014 0.019% 0.011% 6.71E-05 0.020% 0.016% 2.60E-02
ko00300 1.043% 1.102% 8.74E-05 1.039% 1.064% 4.76E-02
ko00983 0.579% 0.548% 9.11E-05 0.588% 0.589% 8.33E-01
ko00281 0.050% 0.030% 9.71E-05 0.058% 0.049% 4.42E-02
ko00910 1.613% 1.448% 1.03E-04 1.680% 1.622% 3.51E-02
ko00360 0.396% 0.352% 1.04E-04 0.395% 0.385% 2.58E-01
ko00270 1.736% 1.827% 1.29E-04 1.703% 1.730% 1.65E-01
ko00643 0.027% 0.017% 1.33E-04 0.021% 0.020% 4.31E-01
ko00720 1.622% 1.514% 1.42E-04 1.663% 1.645% 3.71E-01
Note: Pathways in bold were reproduced (p < 0.05) in population WGSS DC
1 P value based on two-sided Wald chi-squared test after adjustment for age, sex, and body mass index
doi:10.1371/journal.pone.0155362.t006
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difference when comparing 16S rRNA sequencing to whole-genome shotgun metagenomic
studies and should be studied in more detail in the future.
For our second aim, the WGSS DC did reproduce some of the specific, statistically signifi-
cant genes, modules, and pathways detected in population F with CRC case status [8]. Two
related modules and pathways were identified in independent models: M00011 (Citrate cycle,
second carbon oxidation, 2-oxoglutarate => oxaloacetate) and ko00020 (citrate cycle/TCA
cycle); and M00036 (leucine degradation, leucine => acetoacetate + acetyl-CoA) and
ko00280 (valine, leucine, and isoleucine degradation). It is possible that these, and other func-
tional capabilities are related to CRC, but further studies are needed. Shannon diversity, rich-
ness, and evenness based on whole-genome shotgun metagenomics were not associated with
CRC case status in the WGSS DC, but these estimates were similar to those in MetaHIT and
population F.
Our reproducibility of statistically significant associations from a previous study [8] pro-
vides important information about future data pooling given the large differences between
these two sets of data. Our samples were collected in the 1980s in the United States while the
samples for population F were collected in the 2000s in France. There is some evidence that
storage of fecal samples at low temperatures maintains the microbial community structure [20,
21], however, to our knowledge, this has not been tested for samples stored for almost 30 years.
And given previous work that suggests that microbial associations with Type 2 diabetes may
differ by population [22, 23], although these differences may be driven by metformin use [24],
it is encouraging that some of the associations were robust between populations in the United
States and France from different years. Additionally, the fecal samples in our study were col-
lected prior to hospitalization and treatment from all bowel movements over the course of two
days and then freeze-dried. This contrasts with the methods for population F, where samples
were collected 2 weeks to 3 days before colonoscopy, but always prior to bowel cleansing, and
were an aliquot from one bowel movement which was frozen within four hours. Freeze-drying
of fecal samples has been found to potentially affect the relative abundances of different taxa
for infant fecal samples [25], so it is reassuring to replicate some findings between different
storage methods. In addition, the WGSS samples appeared to have similar diversity measures
compared to another shotgun metagenomic study, MetaHIT, which also included a different
population and collections. As has been seen in human genome-wide association studies, large
sample sizes are needed to detect associations that survive correction for multiple testing. With
these differences in time period of collection, population, and sample collection, the similarities
in associations between microbial taxonomic and gene-level data with CRC case status pro-
vides some support for the pooling of data across heterogeneous studies. Additional work has
been conducted to assess the ideal collection methods for future fecal collections [26–30] and
the effect of laboratory handling procedures and bioinformatic processing of the data [31] that
can provide additional information for downstream data pooling or meta-analysis.
Other previous studies have investigated associations between the fecal microbiome and
CRC [32]. Similar to our findings, a number of studies did not detect an overall difference
between CRC cases and controls for measures of community diversity [4, 5, 9]. However, one
study observed that CRC cases had increased gene and genus richness compared to controls
[3], while another study detected reduced gene richness and gene alpha diversity in CRC cases
compared to controls, although the association was not statistically significant after adjust-
ment for fecal sample collection after colonoscopy [6]. In agreement with our findings, most
previous studies found that CRC cases were more likely to have detectable or higher levels of
Fusobacterium compared to controls [3, 5–7, 9], while only some studies detected higher levels
or detection of Porphyromonas in CRC cases compared to controls [3, 5, 7]. In a previous
whole-genome shotgun metagenomic study, the module M00036 and KEGG pathways
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ko00280 and ko00910 were found to be significantly enriched in CRC cases compared to con-
trols [6] similar to what was detected in this study. In the other previous whole-genome shot-
gun metagenomic study, our findings for KEGG pathways ko00020, ko00280, ko00281,
ko00300, ko00785 were confirmed, but an association for KEGG pathway ko00910 was in the
opposite direction from what we observed [3]. In summary, we confirmed some associations
observed in previous research, but all previous studies (16S and whole-genome shotgun
sequencing) had low power. Furthermore, these previous studies may not have been able to
adequately adjust for potential confounders, which could explain some of the variability
between studies. Due to the multiple comparisons in microbiome analyses, data pooling will
be critical to overcoming the limited power in these analyses.
The current study is not without limitations. First, all of the fecal samples were collected
cross-sectionally, so it is not possible to determine if the microbial changes occurred prior to
cancer development or if they were due to the development of cancer. In addition, this study
had a relatively small sample size and therefore, we were underpowered to detect many statisti-
cally significant associations after correction for multiple testing. Finally, our healthy controls
were hospital based controls awaiting elective surgery and may not represent the general popu-
lation at that time. However, our study also has strengths. We were able to leverage existing
sample resources that were collected over 30 years ago and to reproduce associations with CRC
from a current study. Our fecal sample was from a two day collection which may be more rep-
resentative of the typical gut microbiome. We also were able to utilize other existing data
sources for comparison.
In this study, we were able to use whole-genome shotgun metagenomic sequencing to
reproduce a number of significant findings in the same population that was assessed using
16S rRNA gene sequencing [2]. The current study also reproduced some significant gene-
level associations with CRC from a previous whole-genome shotgun metagenomic study of
patients in France [8]. Future studies pooling data across time, population, and sample col-
lection method will help overcome some of the statistical power issues facing epidemiologic
studies of the microbiome and will be key to identifying important associations that may be
involved in CRC detection or prevention. In addition, since all current studies are cross-sec-
tional, it is imperative that prospective cohort studies include a fecal sample collection in
order to study the effect of the human gut microbiome on adverse health outcomes, like
CRC.
Supporting Information
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(XLS)
Acknowledgments
This project was supported by the Intramural Research Program of the National Cancer Insti-
tute. A portion of the data analysis was conducting using the computational resources of the
National Institutes of Health HPC Biowulf cluster (http://hpc.nih.gov). GZ, SS, AYV, RH, and
Colorectal Cancer and the Human Gut Microbiome
PLOSONE | DOI:10.1371/journal.pone.0155362 May 12, 2016 11 / 13
PB received funding through the CancerBiome project (European Research Council project
reference 268985).
Author Contributions
Conceived and designed the experiments: GZ SS AYV RH JJG PB RS. Performed the experi-
ments: GZ SS AYV RH PB. Analyzed the data: EV XH GZ JS. Wrote the paper: EV XH GZ SS
AYV RH JJG JS PB RS.
References
1. Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nature
reviews Microbiology. 2014 Oct; 12(10):661–72. doi: 10.1038/nrmicro3344 PMID: 25198138
2. Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, et al. Human gut microbiome and risk for colorectal
cancer. Journal of the National Cancer Institute. 2013 Dec 18; 105(24):1907–11. doi: 10.1093/jnci/
djt300 PMID: 24316595
3. Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colo-
rectal adenoma-carcinoma sequence. Nature communications. 2015; 6:6528. doi: 10.1038/
ncomms7528 PMID: 25758642
4. Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP. Stool microbiome and metabo-
lome differences between colorectal cancer patients and healthy adults. PloS one. 2013; 8(8):e70803.
doi: 10.1371/journal.pone.0070803 PMID: 23940645
5. WuN, Yang X, Zhang R, Li J, Xiao X, Hu Y, et al. Dysbiosis signature of fecal microbiota in colorectal
cancer patients. Microbial ecology. 2013 Aug; 66(2):462–70. doi: 10.1007/s00248-013-0245-9 PMID:
23733170
6. Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, et al. Metagenomic analysis of faecal microbiome
as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 2015 Sep 25.
7. Zackular JP, Rogers MA, Ruffin MTT, Schloss PD. The human gut microbiome as a screening tool for
colorectal cancer. Cancer prevention research (Philadelphia, Pa). 2014 Nov; 7(11):1112–21.
8. Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, et al. Potential of fecal microbiota for
early-stage detection of colorectal cancer. Molecular systems biology. 2014; 10:766. doi: 10.15252/
msb.20145645 PMID: 25432777
9. Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A, et al. Microbial mucosal
colonic shifts associated with the development of colorectal cancer reveal the presence of different bac-
terial and archaeal biomarkers. J Gastroenterol. 2015 Feb; 50(2):167–79. doi: 10.1007/s00535-014-
0963-x PMID: 24811328
10. Lepage P, Leclerc MC, Joossens M, Mondot S, Blottiere HM, Raes J, et al. A metagenomic insight into
our gut's microbiome. Gut. 2013 Jan; 62(1):146–58. doi: 10.1136/gutjnl-2011-301805 PMID: 22525886
11. Schiffman MH, Van Tassell RL, Robinson A, Smith L, Daniel J, Hoover RN, et al. Case-control study of
colorectal cancer and fecapentaene excretion. Cancer Res. 1989 Mar 1; 49(5):1322–6. PMID:
2917361
12. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut micro-
biome correlates with metabolic markers. Nature. 2013 Aug 29; 500(7464):541–6. doi: 10.1038/
nature12506 PMID: 23985870
13. Qin J, Li R, Raes J, ArumugamM, Burgdorf KS, Manichanh C, et al. A human gut microbial gene cata-
logue established by metagenomic sequencing. Nature. 2010 Mar 4; 464(7285):59–65. doi: 10.1038/
nature08821 PMID: 20203603
14. The HumanMicrobiome Project Consortium. Structure, function and diversity of the healthy human
microbiome. Nature. 2012 Jun 14; 486(7402):207–14. doi: 10.1038/nature11234 PMID: 22699609
15. Sunagawa S, Mende DR, Zeller G, Izquierdo-Carrasco F, Berger SA, Kultima JR, et al. Metagenomic
species profiling using universal phylogenetic marker genes. Nature methods. 2013 Dec; 10(12):1196–
9. doi: 10.1038/nmeth.2693 PMID: 24141494
16. Mende DR, Sunagawa S, Zeller G, Bork P. Accurate and universal delineation of prokaryotic species.
Nature methods. 2013 Sep; 10(9):881–4. doi: 10.1038/nmeth.2575 PMID: 23892899
17. Kultima JR, Sunagawa S, Li J, ChenW, Chen H, Mende DR, et al. MOCAT: a metagenomics assembly
and gene prediction toolkit. PloS one. 2012; 7(10):e47656. doi: 10.1371/journal.pone.0047656 PMID:
23082188
Colorectal Cancer and the Human Gut Microbiome
PLOSONE | DOI:10.1371/journal.pone.0155362 May 12, 2016 12 / 13
18. Kanehisa M, Araki M, Goto S, Hattori M, HirakawaM, Itoh M, et al. KEGG for linking genomes to life
and the environment. Nucleic acids research. 2008 Jan; 36(Database issue):D480–4. PMID: 18077471
19. Oksanen J, Kindt R, Legendre P, O’Hara B, Stevens MHH, Oksanen MJ, et al. The vegan package.
Community ecology package. 2007:631–7.
20. Lauber CL, Zhou N, Gordon JI, Knight R, Fierer N. Effect of storage conditions on the assessment of
bacterial community structure in soil and human-associated samples. FEMSmicrobiology letters. 2010
Jun; 307(1):80–6. doi: 10.1111/j.1574-6968.2010.01965.x PMID: 20412303
21. Carroll IM, Ringel-Kulka T, Siddle JP, Klaenhammer TR, Ringel Y. Characterization of the fecal micro-
biota using high-throughput sequencing reveals a stable microbial community during storage. PloS
one. 2012; 7(10):e46953. doi: 10.1371/journal.pone.0046953 PMID: 23071673
22. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in
type 2 diabetes. Nature. 2012 Oct 4; 490(7418):55–60. doi: 10.1038/nature11450 PMID: 23023125
23. Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B, et al. Gut metagenome in
European women with normal, impaired and diabetic glucose control. Nature. 2013 Jun 6; 498
(7452):99–103. doi: 10.1038/nature12198 PMID: 23719380
24. Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, et al. Disentangling type 2
diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015 Dec 10; 528
(7581):262–6. doi: 10.1038/nature15766 PMID: 26633628
25. Lewis ZT, Davis JC, Smilowitz JT, German JB, Lebrilla CB, Mills DA. The impact of freeze-drying infant
fecal samples on measures of their bacterial community profiles and milk-derived oligosaccharide con-
tent. PeerJ. 2016; 4:e1612. doi: 10.7717/peerj.1612 PMID: 26819854
26. Flores R, Shi J, Yu G, Ma B, Ravel J, Goedert JJ, et al. Collection media and delayed freezing effects
on microbial composition of human stool. Microbiome. 2015; 3:33. doi: 10.1186/s40168-015-0092-7
PMID: 26269741
27. Dominianni C, Wu J, Hayes RB, Ahn J. Comparison of methods for fecal microbiome biospecimen col-
lection. BMCmicrobiology. 2014; 14:103. doi: 10.1186/1471-2180-14-103 PMID: 24758293
28. Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, Earl AM, et al. Relating the metatranscrip-
tome and metagenome of the human gut. Proceedings of the National Academy of Sciences of the
United States of America. 2014 Jun 3; 111(22):E2329–38. doi: 10.1073/pnas.1319284111 PMID:
24843156
29. Voigt AY, Costea PI, Kultima JR, Li SS, Zeller G, Sunagawa S, et al. Temporal and technical variability
of human gut metagenomes. Genome biology. 2015; 16:73. doi: 10.1186/s13059-015-0639-8 PMID:
25888008
30. Sinha R, Chen J, Amir A, Vogtmann E, Shi J, Inman KS, et al. Collecting Fecal Samples for Microbiome
Analyses in Epidemiology Studies. Cancer epidemiology, biomarkers & prevention: a publication of the
American Association for Cancer Research, cosponsored by the American Society of Preventive
Oncology. 2015 Nov 24.
31. Sinha R, Abnet CC, White O, Knight R, Huttenhower C. The microbiome quality control project: base-
line study design and future directions. Genome biology. 2015; 16:276. doi: 10.1186/s13059-015-0841-
8 PMID: 26653756
32. Vogtmann E, Goedert JJ. Epidemiologic studies of the human microbiome and cancer. British journal of
cancer. 2016 Jan 5.
Colorectal Cancer and the Human Gut Microbiome
PLOSONE | DOI:10.1371/journal.pone.0155362 May 12, 2016 13 / 13
